Wall Street Journal (August 11)
Though “artificial intelligence has the potential to reinvent the world, from how businesses operate to the types of jobs people hold to the way wars are fought,” the struggles of IBM’s Watson “suggest that revolution remains some way off.” Currently, “no published research shows Watson improving patient outcomes” while “more than a dozen IBM partners and clients have halted or shrunk Watson’s oncology-related projects” because of its “limited impact on patients.” Often, “the tools didn’t add much value. In some cases, Watson wasn’t accurate.”
Tags: Accurate, AI, Clients, IBM, Impact, Oncology, Partners, Patient outcomes, Potential, Revolution, Struggles, Watson
Boston Globe (February 20)
In 1997, IBM’s Deep Blue supercomputer beat World Chess Champion Garry Kasparov in a six-game match. Last week, IBM’s latest supercomputer Watson beat two contestants on the highly colloquial American game show Jeopardy. Is the “age of the neuron” over? The Boston Globe doesn’t think so. “In many ways, even a computer as advanced as Watson lacks the capabilities packed into every human skull. What Watson really shows is the extent of human ingenuity, in the form of its makers.”
Tags: IBM, Neuron, Supercomputer, Watson
